191 related articles for article (PubMed ID: 22844114)
1. GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways.
Bhattarai N; McLinden JH; Xiang J; Kaufman TM; Stapleton JT
J Immunol; 2012 Sep; 189(5):2211-6. PubMed ID: 22844114
[TBL] [Abstract][Full Text] [Related]
2. GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling.
Bhattarai N; McLinden JH; Xiang J; Landay AL; Chivero ET; Stapleton JT
J Immunol; 2013 Jun; 190(12):6351-9. PubMed ID: 23686495
[TBL] [Abstract][Full Text] [Related]
3. Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4⁺ T-cells.
McLinden JH; Stapleton JT; Klinzman D; Murthy KK; Chang Q; Kaufman TM; Bhattarai N; Xiang J
J Gen Virol; 2013 Apr; 94(Pt 4):774-782. PubMed ID: 23288422
[TBL] [Abstract][Full Text] [Related]
4. GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates.
Mohr EL; Xiang J; McLinden JH; Kaufman TM; Chang Q; Montefiori DC; Klinzman D; Stapleton JT
J Immunol; 2010 Oct; 185(7):4496-505. PubMed ID: 20826757
[TBL] [Abstract][Full Text] [Related]
5. GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T-cell death.
Rydze RT; Bhattarai N; Stapleton JT
Antivir Ther; 2012; 17(7):1271-9. PubMed ID: 22951385
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication.
Xiang J; McLinden JH; Kaufman TM; Mohr EL; Bhattarai N; Chang Q; Stapleton JT
Virology; 2012 Aug; 430(1):53-62. PubMed ID: 22608061
[TBL] [Abstract][Full Text] [Related]
7. GB virus type C interactions with HIV: the role of envelope glycoproteins.
Mohr EL; Stapleton JT
J Viral Hepat; 2009 Nov; 16(11):757-68. PubMed ID: 19758271
[TBL] [Abstract][Full Text] [Related]
8. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.
Stapleton JT; Chaloner K; Zhang J; Klinzman D; Souza IE; Xiang J; Landay A; Fahey J; Pollard R; Mitsuyasu R
AIDS; 2009 Mar; 23(5):605-10. PubMed ID: 19194270
[TBL] [Abstract][Full Text] [Related]
9. Influence of GB virus C on IFN-γ and IL-2 production and CD38 expression in T lymphocytes from chronically HIV-infected and HIV-HCV-co-infected patients.
Baggio-Zappia GL; Barbosa Ade J; Brunialti MK; Salomão R; Granato CF
Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):662-9. PubMed ID: 22012219
[TBL] [Abstract][Full Text] [Related]
10. An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells.
Xiang J; McLinden JH; Chang Q; Kaufman TM; Stapleton JT
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15570-5. PubMed ID: 17030806
[TBL] [Abstract][Full Text] [Related]
11. GB virus type C E2 protein inhibits human immunodeficiency virus type 1 assembly through interference with HIV-1 gag plasma membrane targeting.
Timmons CL; Shao Q; Wang C; Liu L; Liu H; Dong X; Liu B
J Infect Dis; 2013 Apr; 207(7):1171-80. PubMed ID: 23303812
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected].
Eissmann K; Mueller S; Sticht H; Jung S; Zou P; Jiang S; Gross A; Eichler J; Fleckenstein B; Reil H
PLoS One; 2013; 8(1):e54452. PubMed ID: 23349893
[TBL] [Abstract][Full Text] [Related]
13. A novel T cell evasion mechanism in persistent RNA virus infection.
Stapleton JT; Xiang J; McLinden JH; Bhattarai N; Chivero ET; Klinzman D; Kaufman TM; Chang Q
Trans Am Clin Climatol Assoc; 2014; 125():14-24; discussion 24-6. PubMed ID: 25125715
[TBL] [Abstract][Full Text] [Related]
14. The GBV-C envelope glycoprotein E2 does not interact specifically with CD81.
Kaufman TM; McLinden JH; Xiang J; Engel AM; Stapleton JT
AIDS; 2007 May; 21(8):1045-8. PubMed ID: 17457101
[TBL] [Abstract][Full Text] [Related]
15. Conserved Motifs within Hepatitis C Virus Envelope (E2) RNA and Protein Independently Inhibit T Cell Activation.
Bhattarai N; McLinden JH; Xiang J; Kaufman TM; Stapleton JT
PLoS Pathog; 2015 Sep; 11(9):e1005183. PubMed ID: 26421924
[TBL] [Abstract][Full Text] [Related]
16. Impact of GB virus C viraemia on clinical outcome in HIV-1-infected patients: a 20-year follow-up study.
Ernst D; Greer M; Akmatova R; Pischke S; Wedemeyer H; Heiken H; Tillmann HL; Schmidt RE; Stoll M
HIV Med; 2014 Apr; 15(4):245-50. PubMed ID: 24118889
[TBL] [Abstract][Full Text] [Related]
17. Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.
Xiang J; McLinden JH; Rydze RA; Chang Q; Kaufman TM; Klinzman D; Stapleton JT
J Immunol; 2009 Dec; 183(12):7860-9. PubMed ID: 19923460
[TBL] [Abstract][Full Text] [Related]
18. Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.
Koedel Y; Eissmann K; Wend H; Fleckenstein B; Reil H
J Virol; 2011 Jul; 85(14):7037-47. PubMed ID: 21543477
[TBL] [Abstract][Full Text] [Related]
19. Effect of primer selection on estimates of GB virus C (GBV-C) prevalence and response to antiretroviral therapy for optimal testing for GBV-C viremia.
Souza IE; Allen JB; Xiang J; Klinzman D; Diaz R; Zhang S; Chaloner K; Zdunek D; Hess G; Williams CF; Benning L; Stapleton JT
J Clin Microbiol; 2006 Sep; 44(9):3105-13. PubMed ID: 16954234
[TBL] [Abstract][Full Text] [Related]
20. Ethanol inhibits lipid raft-mediated TCR signaling and IL-2 expression: potential mechanism of alcohol-induced immune suppression.
Ghare S; Patil M; Hote P; Suttles J; McClain C; Barve S; Joshi-Barve S
Alcohol Clin Exp Res; 2011 Aug; 35(8):1435-44. PubMed ID: 21463338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
